Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 15 entries
Sorted by: Best Match Show Resources per page
[In Process Citation].

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie

Odievre M.
PMID: 10904707
Arch Pediatr. 2000 May;7:193s. doi: 10.1016/s0929-693x(00)80034-2.

No abstract available.

Cite
Odievre M. Fratries d'enfants atteints de maladie chronique. [In Process Citation]. Arch Pediatr. 2000;7:193sdoi: 10.1016/s0929-693x(00)80034-2.
Odievre, M. (2000). Fratries d'enfants atteints de maladie chronique. [In Process Citation]. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 7193s. https://doi.org/10.1016/s0929-693x(00)80034-2
Odievre. "Fratries d'enfants atteints de maladie chronique." [In Process Citation]. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie vol. 7 (2000): 193s. doi: https://doi.org/10.1016/s0929-693x(00)80034-2
Odievre M. Fratries d'enfants atteints de maladie chronique. [In Process Citation]. Arch Pediatr. 2000 May;7:193s. doi: 10.1016/s0929-693x(00)80034-2. French. PMID: 10904707.
Copy Download .nbib Format: NLM
[A new section: daily pediatrics].

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie

David L, Odièvre M.
PMID: 10223102
Arch Pediatr. 1998 Jan;5(1):1-2. doi: 10.1016/s0929-693x(97)83457-4.

No abstract available.

Cite
David L, Odièvre M. Une nouvelle rubrique: pédiatrie au quotidien. [A new section: daily pediatrics]. Arch Pediatr. 1998;5(1):1-2doi: 10.1016/s0929-693x(97)83457-4.
David, L., & Odièvre, M. (1998). Une nouvelle rubrique: pédiatrie au quotidien. [A new section: daily pediatrics]. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 5(1), 1-2. https://doi.org/10.1016/s0929-693x(97)83457-4
David, L, and Odièvre, M. "Une nouvelle rubrique: pédiatrie au quotidien." [A new section: daily pediatrics]. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie vol. 5,1 (1998): 1-2. doi: https://doi.org/10.1016/s0929-693x(97)83457-4
David L, Odièvre M. Une nouvelle rubrique: pédiatrie au quotidien. [A new section: daily pediatrics]. Arch Pediatr. 1998 Jan;5(1):1-2. doi: 10.1016/s0929-693x(97)83457-4. French. PMID: 10223102.
Copy Download .nbib Format: NLM
[Methodology of preparing a list of educational objectives: example of application to pharmacology. Groupe Objectifs Pédagogiques de L'Association des Enseignants de Pharmacologie].

Therapie

Boissel JP, Autret E, Bechtel P, Bourin M, Funk-Brentano C, Lièvre M, Paintaud G, Pons G.
PMID: 9164002
Therapie. 1996 Nov-Dec;51(6):655-66.

Using a structured approach to categorize pharmacological knowledge and a systemic analysis of prescribing practice, we identified the knowledge needed to optimally prescribe and manage treatments with drugs. The approach consisted in finding the branched chains of knowledge beginning...

Cite
Boissel JP, Autret E, Bechtel P, et al. Méthodologie d'élaboration d'une liste d'objectifs éducationnels: exemple d'application à la pharmacologie. Groupe Objectifs Pédagogiques de l'Association des Enseignants de Pharmacologie. [Methodology of preparing a list of educational objectives: example of application to pharmacology. Groupe Objectifs Pédagogiques de L'Association des Enseignants de Pharmacologie]. Therapie. 1996;51(6):655-66
Boissel, J. P., Autret, E., Bechtel, P., Bourin, M., Funk-Brentano, C., Lièvre, M., Paintaud, G., & Pons, G. (1996). Méthodologie d'élaboration d'une liste d'objectifs éducationnels: exemple d'application à la pharmacologie. Groupe Objectifs Pédagogiques de l'Association des Enseignants de Pharmacologie. [Methodology of preparing a list of educational objectives: example of application to pharmacology. Groupe Objectifs Pédagogiques de L'Association des Enseignants de Pharmacologie]. Therapie, 51(6), 655-66.
Boissel, J P, et al. "Méthodologie d'élaboration d'une liste d'objectifs éducationnels: exemple d'application à la pharmacologie. Groupe Objectifs Pédagogiques de l'Association des Enseignants de Pharmacologie." [Methodology of preparing a list of educational objectives: example of application to pharmacology. Groupe Objectifs Pédagogiques de L'Association des Enseignants de Pharmacologie]. Therapie vol. 51,6 (1996): 655-66.
Boissel JP, Autret E, Bechtel P, Bourin M, Funk-Brentano C, Lièvre M, Paintaud G, Pons G. Méthodologie d'élaboration d'une liste d'objectifs éducationnels: exemple d'application à la pharmacologie. Groupe Objectifs Pédagogiques de l'Association des Enseignants de Pharmacologie. [Methodology of preparing a list of educational objectives: example of application to pharmacology. Groupe Objectifs Pédagogiques de L'Association des Enseignants de Pharmacologie]. Therapie. 1996 Nov-Dec;51(6):655-66. French. PMID: 9164002.
Copy Download .nbib Format: NLM
Risk factors for severe COVID-19 in hospitalized sickle cell disease patients: A study of 319 patients in France.

American journal of hematology

Arlet JB, Lionnet F, Khimoud D, Joseph L, de Montalembert M, Morisset S, Garou A, Cannas G, Cougoul P, Guitton C, Holvoet L, Odièvre MH, Cheminet G, Bartolucci P, Santin A, Bernit E, de Luna G.
PMID: 34882837
Am J Hematol. 2021 Dec 09; doi: 10.1002/ajh.26432. Epub 2021 Dec 09.

No abstract available.

Cite
Arlet JB, Lionnet F, Khimoud D, et al. Risk factors for severe COVID-19 in hospitalized sickle cell disease patients: A study of 319 patients in France. Am J Hematol. 2021;doi: 10.1002/ajh.26432.
Arlet, J. B., Lionnet, F., Khimoud, D., Joseph, L., de Montalembert, M., Morisset, S., Garou, A., Cannas, G., Cougoul, P., Guitton, C., Holvoet, L., Odièvre, M. H., Cheminet, G., Bartolucci, P., Santin, A., Bernit, E., de Luna, G. (2021). Risk factors for severe COVID-19 in hospitalized sickle cell disease patients: A study of 319 patients in France. American journal of hematology, . https://doi.org/10.1002/ajh.26432
Arlet, Jean-Benoît, et al. "Risk factors for severe COVID-19 in hospitalized sickle cell disease patients: A study of 319 patients in France." American journal of hematology vol. (2021). doi: https://doi.org/10.1002/ajh.26432
Arlet JB, Lionnet F, Khimoud D, Joseph L, de Montalembert M, Morisset S, Garou A, Cannas G, Cougoul P, Guitton C, Holvoet L, Odièvre MH, Cheminet G, Bartolucci P, Santin A, Bernit E, de Luna G. Risk factors for severe COVID-19 in hospitalized sickle cell disease patients: A study of 319 patients in France. Am J Hematol. 2021 Dec 09; doi: 10.1002/ajh.26432. Epub 2021 Dec 09. PMID: 34882837.
Copy Download .nbib Format: NLM
Short- and Mid-Term Outcomes of Endovascular Stenting for the Treatment of Post-Thrombotic Syndrome due to Iliofemoral and Caval Occlusive Disease: A Multi-Centric Study from the French Society of Diagnostic and Interventional Cardiovascular Imaging (SFICV).

Cardiovascular and interventional radiology

David A, Thony F, Del Giudice C, Goyault G, Loffroy R, Guillen K, Le Bras Y, Marcelin C, Monnin-Bares V, Heautot JF, Lablee A, Marek P, Rousseau H, Martinelli T, Thouveny F, Barral PA, Le Pennec V, Chabrot P, Rogopoulos A, Guillien A, Sapoval M, Rodière M, Espitia O, Douane F.
PMID: 34981196
Cardiovasc Intervent Radiol. 2022 Jan 04; doi: 10.1007/s00270-021-03038-2. Epub 2022 Jan 04.

PURPOSE: To assess the results of endovascular treatment in a large population of patients suffering from post-thrombotic syndrome (PTS) due to iliocaval occlusive disease.METHODS: In this retrospective multi-center study, 698 patients treated by stenting for PTS in 15 French...

Cite
David A, Thony F, Del Giudice C, et al. Short- and Mid-Term Outcomes of Endovascular Stenting for the Treatment of Post-Thrombotic Syndrome due to Iliofemoral and Caval Occlusive Disease: A Multi-Centric Study from the French Society of Diagnostic and Interventional Cardiovascular Imaging (SFICV). Cardiovasc Intervent Radiol. 2022;doi: 10.1007/s00270-021-03038-2.
David, A., Thony, F., Del Giudice, C., Goyault, G., Loffroy, R., Guillen, K., Le Bras, Y., Marcelin, C., Monnin-Bares, V., Heautot, J. F., Lablee, A., Marek, P., Rousseau, H., Martinelli, T., Thouveny, F., Barral, P. A., Le Pennec, V., Chabrot, P., Rogopoulos, A., Guillien, A., Sapoval, M., Rodière, M., Espitia, O., Douane, F. (2022). Short- and Mid-Term Outcomes of Endovascular Stenting for the Treatment of Post-Thrombotic Syndrome due to Iliofemoral and Caval Occlusive Disease: A Multi-Centric Study from the French Society of Diagnostic and Interventional Cardiovascular Imaging (SFICV). Cardiovascular and interventional radiology, . https://doi.org/10.1007/s00270-021-03038-2
David, Arthur, et al. "Short- and Mid-Term Outcomes of Endovascular Stenting for the Treatment of Post-Thrombotic Syndrome due to Iliofemoral and Caval Occlusive Disease: A Multi-Centric Study from the French Society of Diagnostic and Interventional Cardiovascular Imaging (SFICV)." Cardiovascular and interventional radiology vol. (2022). doi: https://doi.org/10.1007/s00270-021-03038-2
David A, Thony F, Del Giudice C, Goyault G, Loffroy R, Guillen K, Le Bras Y, Marcelin C, Monnin-Bares V, Heautot JF, Lablee A, Marek P, Rousseau H, Martinelli T, Thouveny F, Barral PA, Le Pennec V, Chabrot P, Rogopoulos A, Guillien A, Sapoval M, Rodière M, Espitia O, Douane F. Short- and Mid-Term Outcomes of Endovascular Stenting for the Treatment of Post-Thrombotic Syndrome due to Iliofemoral and Caval Occlusive Disease: A Multi-Centric Study from the French Society of Diagnostic and Interventional Cardiovascular Imaging (SFICV). Cardiovasc Intervent Radiol. 2022 Jan 04; doi: 10.1007/s00270-021-03038-2. Epub 2022 Jan 04. PMID: 34981196.
Copy Download .nbib Format: NLM
High Post-Procedural Transvalvular Gradient or Delayed Mean Gradient Increase after Transcatheter Aortic Valve Implantation: Incidence, Prognosis and Associated Variables. The FRANCE-2 Registry.

Journal of clinical medicine

Didier R, Benic C, Nasr B, Le Ven F, Hannachi S, Eltchaninoff H, Koifman E, Donzeau-Gouge P, Fajadet J, Leprince P, Leguerrier A, Lièvre M, Prat A, Teiger E, Lefevre T, Cuisset T, Le Breton H, Auffret V, Iung B, Gilard M.
PMID: 34362005
J Clin Med. 2021 Jul 22;10(15). doi: 10.3390/jcm10153221.

Mean Gradient (MG) elevation can be detected immediately after transcatheter aortic valve implantation (TAVI) or secondarily during follow-up. Comparisons and interactions between these two parameters and their impact on outcomes have not previously been investigated. This study aimed to...

Cite
Didier R, Benic C, Nasr B, et al. High Post-Procedural Transvalvular Gradient or Delayed Mean Gradient Increase after Transcatheter Aortic Valve Implantation: Incidence, Prognosis and Associated Variables. The FRANCE-2 Registry. J Clin Med. 2021;10(15)doi: 10.3390/jcm10153221.
Didier, R., Benic, C., Nasr, B., Le Ven, F., Hannachi, S., Eltchaninoff, H., Koifman, E., Donzeau-Gouge, P., Fajadet, J., Leprince, P., Leguerrier, A., Lièvre, M., Prat, A., Teiger, E., Lefevre, T., Cuisset, T., Le Breton, H., Auffret, V., Iung, B., & Gilard, M. (2021). High Post-Procedural Transvalvular Gradient or Delayed Mean Gradient Increase after Transcatheter Aortic Valve Implantation: Incidence, Prognosis and Associated Variables. The FRANCE-2 Registry. Journal of clinical medicine, 10(15), . https://doi.org/10.3390/jcm10153221
Didier, Romain, et al. "High Post-Procedural Transvalvular Gradient or Delayed Mean Gradient Increase after Transcatheter Aortic Valve Implantation: Incidence, Prognosis and Associated Variables. The FRANCE-2 Registry." Journal of clinical medicine vol. 10,15 (2021). doi: https://doi.org/10.3390/jcm10153221
Didier R, Benic C, Nasr B, Le Ven F, Hannachi S, Eltchaninoff H, Koifman E, Donzeau-Gouge P, Fajadet J, Leprince P, Leguerrier A, Lièvre M, Prat A, Teiger E, Lefevre T, Cuisset T, Le Breton H, Auffret V, Iung B, Gilard M. High Post-Procedural Transvalvular Gradient or Delayed Mean Gradient Increase after Transcatheter Aortic Valve Implantation: Incidence, Prognosis and Associated Variables. The FRANCE-2 Registry. J Clin Med. 2021 Jul 22;10(15). doi: 10.3390/jcm10153221. PMID: 34362005; PMCID: PMC8347874.
Copy Download .nbib Format: NLM
[Archives of Pediatrics 2003: continuity and changes].

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie

Dehan M, Odièvre M.
PMID: 12818771
Arch Pediatr. 2003 Jan;10(1):1. doi: 10.1016/s0929-693x(03)00212-4.

No abstract available.

Cite
Dehan M, Odièvre M. Les Archives de pédiatrie 2003: continuité et changements. [Archives of Pediatrics 2003: continuity and changes]. Arch Pediatr. 2003;10(1):1doi: 10.1016/s0929-693x(03)00212-4.
Dehan, M., & Odièvre, M. (2003). Les Archives de pédiatrie 2003: continuité et changements. [Archives of Pediatrics 2003: continuity and changes]. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 10(1), 1. https://doi.org/10.1016/s0929-693x(03)00212-4
Dehan, M, and Odièvre, M. "Les Archives de pédiatrie 2003: continuité et changements." [Archives of Pediatrics 2003: continuity and changes]. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie vol. 10,1 (2003): 1. doi: https://doi.org/10.1016/s0929-693x(03)00212-4
Dehan M, Odièvre M. Les Archives de pédiatrie 2003: continuité et changements. [Archives of Pediatrics 2003: continuity and changes]. Arch Pediatr. 2003 Jan;10(1):1. doi: 10.1016/s0929-693x(03)00212-4. French. PMID: 12818771.
Copy Download .nbib Format: NLM
Evaluation of Outcomes and Quality of Care in Children with Sickle Cell Disease Diagnosed by Newborn Screening: A Real-World Nation-Wide Study in France.

Journal of clinical medicine

Brousse V, Arnaud C, Lesprit E, Quinet B, Odièvre MH, Etienne-Julan M, Guillaumat C, Elana G, Belloy M, Garnier N, Chamouine A, Dumesnil C, Montalembert M, Pondarre C, Bernaudin F, Couque N, Boutin E, Bardakjian J, Djennaoui F, Ithier G, Benkerrou M, Thuret I.
PMID: 31581727
J Clin Med. 2019 Oct 02;8(10). doi: 10.3390/jcm8101594.

This study's objective was to assess, on a national scale, residual risks of death, major disease-related events, and quality of care during the first five years in children diagnosed at birth with sickle cell disease (SCD). Data were retrospectively...

Cite
Brousse V, Arnaud C, Lesprit E, et al. Evaluation of Outcomes and Quality of Care in Children with Sickle Cell Disease Diagnosed by Newborn Screening: A Real-World Nation-Wide Study in France. J Clin Med. 2019;8(10)doi: 10.3390/jcm8101594.
Brousse, V., Arnaud, C., Lesprit, E., Quinet, B., Odièvre, M. H., Etienne-Julan, M., Guillaumat, C., Elana, G., Belloy, M., Garnier, N., Chamouine, A., Dumesnil, C., Montalembert, M., Pondarre, C., Bernaudin, F., Couque, N., Boutin, E., Bardakjian, J., Djennaoui, F., Ithier, G., Benkerrou, M., & Thuret, I. (2019). Evaluation of Outcomes and Quality of Care in Children with Sickle Cell Disease Diagnosed by Newborn Screening: A Real-World Nation-Wide Study in France. Journal of clinical medicine, 8(10), . https://doi.org/10.3390/jcm8101594
Brousse, Valentine, et al. "Evaluation of Outcomes and Quality of Care in Children with Sickle Cell Disease Diagnosed by Newborn Screening: A Real-World Nation-Wide Study in France." Journal of clinical medicine vol. 8,10 (2019). doi: https://doi.org/10.3390/jcm8101594
Brousse V, Arnaud C, Lesprit E, Quinet B, Odièvre MH, Etienne-Julan M, Guillaumat C, Elana G, Belloy M, Garnier N, Chamouine A, Dumesnil C, Montalembert M, Pondarre C, Bernaudin F, Couque N, Boutin E, Bardakjian J, Djennaoui F, Ithier G, Benkerrou M, Thuret I. Evaluation of Outcomes and Quality of Care in Children with Sickle Cell Disease Diagnosed by Newborn Screening: A Real-World Nation-Wide Study in France. J Clin Med. 2019 Oct 02;8(10). doi: 10.3390/jcm8101594. PMID: 31581727; PMCID: PMC6832704.
Copy Download .nbib Format: NLM
Pooling, meta-analysis, and the evaluation of drug safety.

Current controlled trials in cardiovascular medicine

Lièvre M, Cucherat M, Leizorovicz A.
PMID: 11991807
Curr Control Trials Cardiovasc Med. 2002 Mar 19;3(1):6. doi: 10.1186/1468-6708-3-6.

BACKGROUND: The "integrated safety report" of the drug registration files submitted to health authorities usually summarizes the rates of adverse events observed for a new drug, placebo or active control drugs by pooling the safety data across the trials....

Cite
Lièvre M, Cucherat M, Leizorovicz A. Pooling, meta-analysis, and the evaluation of drug safety. Curr Control Trials Cardiovasc Med. 2002;3(1):6doi: 10.1186/1468-6708-3-6.
Lièvre, M., Cucherat, M., & Leizorovicz, A. (2002). Pooling, meta-analysis, and the evaluation of drug safety. Current controlled trials in cardiovascular medicine, 3(1), 6. https://doi.org/10.1186/1468-6708-3-6
Lièvre, Michel, et al. "Pooling, meta-analysis, and the evaluation of drug safety." Current controlled trials in cardiovascular medicine vol. 3,1 (2002): 6. doi: https://doi.org/10.1186/1468-6708-3-6
Lièvre M, Cucherat M, Leizorovicz A. Pooling, meta-analysis, and the evaluation of drug safety. Curr Control Trials Cardiovasc Med. 2002 Mar 19;3(1):6. doi: 10.1186/1468-6708-3-6. PMID: 11991807; PMCID: PMC134478.
Copy Download .nbib Format: NLM
[Not Available].

Therapie

Alla F, Rosilio M, Funck-Brentano C, Barthélémy P, Brisset S, Cellier D, Chassany O, Demarez JP, Diebolt V, Francillon A, Gambotti L, Hannachi H, Lechat P, Lemaire F, Lièvre M, Misse C, Nguon M, Pariente A, Rosenheim M, Weisslinger-Darmon N.
PMID: 27392724
Therapie. 2013 Jul-Aug;68(4):209-16. doi: 10.2515/therapie/2013035.

No abstract available.

Cite
Alla F, Rosilio M, Funck-Brentano C. Comment garantir des données médicales de qualité dans les études cliniques, pharmaco-épidémiologiques et en pharmacovigilance ? [Not Available]. Therapie. 2013;68(4):209-16doi: 10.2515/therapie/2013035.
Alla, F., Rosilio, M., Funck-Brentano, C., Barthélémy, P., Brisset, S., Cellier, D., Chassany, O., Demarez, J. P., Diebolt, V., Francillon, A., Gambotti, L., Hannachi, H., Lechat, P., Lemaire, F., Lièvre, M., Misse, C., Nguon, M., Pariente, A., Rosenheim, M., & Weisslinger-Darmon, N. (2013). Comment garantir des données médicales de qualité dans les études cliniques, pharmaco-épidémiologiques et en pharmacovigilance ? [Not Available]. Therapie, 68(4), 209-16. https://doi.org/10.2515/therapie/2013035
Alla, François, et al. "Comment garantir des données médicales de qualité dans les études cliniques, pharmaco-épidémiologiques et en pharmacovigilance ?" [Not Available]. Therapie vol. 68,4 (2013): 209-16. doi: https://doi.org/10.2515/therapie/2013035
Alla F, Rosilio M, Funck-Brentano C, Barthélémy P, Brisset S, Cellier D, Chassany O, Demarez JP, Diebolt V, Francillon A, Gambotti L, Hannachi H, Lechat P, Lemaire F, Lièvre M, Misse C, Nguon M, Pariente A, Rosenheim M, Weisslinger-Darmon N. Comment garantir des données médicales de qualité dans les études cliniques, pharmaco-épidémiologiques et en pharmacovigilance ? [Not Available]. Therapie. 2013 Jul-Aug;68(4):209-16. doi: 10.2515/therapie/2013035. French. PMID: 27392724.
Copy Download .nbib Format: NLM
[A review in the service of French language pediatrics].

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie

Odièvre M, David L.
PMID: 8087215
Arch Pediatr. 1994 Jan;1(1):3-4.

No abstract available.

Cite
Odièvre M, David L. Une revue au service de la pédiatrie de langue française. [A review in the service of French language pediatrics]. Arch Pediatr. 1994;1(1):3-4
Odièvre, M., & David, L. (1994). Une revue au service de la pédiatrie de langue française. [A review in the service of French language pediatrics]. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 1(1), 3-4.
Odièvre, M, and David, L. "Une revue au service de la pédiatrie de langue française." [A review in the service of French language pediatrics]. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie vol. 1,1 (1994): 3-4.
Odièvre M, David L. Une revue au service de la pédiatrie de langue française. [A review in the service of French language pediatrics]. Arch Pediatr. 1994 Jan;1(1):3-4. French. PMID: 8087215.
Copy Download .nbib Format: NLM
[Vae soli!].

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie

Odièvre M, David L.
PMID: 9436488
Arch Pediatr. 1997 Oct;4(10):935-6. doi: 10.1016/s0929-693x(97)86086-1.

No abstract available.

Cite
Odièvre M, David L. Vae soli! [Vae soli!]. Arch Pediatr. 1997;4(10):935-6doi: 10.1016/s0929-693x(97)86086-1.
Odièvre, M., & David, L. (1997). Vae soli! [Vae soli!]. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 4(10), 935-6. https://doi.org/10.1016/s0929-693x(97)86086-1
Odièvre, M, and David, L. "Vae soli!" [Vae soli!]. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie vol. 4,10 (1997): 935-6. doi: https://doi.org/10.1016/s0929-693x(97)86086-1
Odièvre M, David L. Vae soli! [Vae soli!]. Arch Pediatr. 1997 Oct;4(10):935-6. doi: 10.1016/s0929-693x(97)86086-1. French. PMID: 9436488.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 15 entries